Optimal timing of G-CSF administration for effective autologous stem cell collection

Area of Science:

• Hematology
• Oncology
• Transplantation Medicine

Background:

• The optimal timing for granulocyte colony-stimulating factor (G-CSF) administration to maximize peripheral blood progenitor cell (PBPC) collection efficiency is not well-established.
• Efficient PBPC collection is crucial for successful autologous stem cell transplantation in patients with hematological malignancies.

Purpose of the Study:

• To determine the optimal timing of G-CSF administration for efficient autologous stem cell collection.
• To compare the efficacy of G-CSF given in the evening (PM group) versus in the morning (AM group) prior to leukapheresis.

Main Methods:

• A retrospective analysis of 262 lymphoma or multiple myeloma patients undergoing PBPC collection between January 2000 and March 2008.
• Patients received lenograstim (G-CSF) at 10 μg/kg/day, either at 20:00 (PM group) or 06:00 (AM group, 3 hours before apheresis).
• Comparison of collected CD34+ cells/kg, apheresis duration, collection efficacy, and optimal harvest yield between the two groups.

Main Results:

• The AM group showed a higher median number of total collected CD34+ cells/kg over a shorter apheresis duration.
• The AM group had a larger median number of CD34+ cells/kg collected at the first leukapheresis.
• Stem cell collection efficacy and the proportion of patients achieving an optimal harvest were significantly higher in the AM group.

Conclusions:

• G-CSF administration 3 hours prior to apheresis significantly improves the efficacy of autologous stem cell collection.
• This optimized timing leads to a greater yield of CD34+ cells and higher collection efficiency.
• The findings support a standardized protocol for G-CSF administration to enhance PBPC collection outcomes.